Stocks and Investing
Stocks and Investing
Wed, March 16, 2022
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
[ Wed, Mar 16th 2022
] - WOPRAI
Tue, March 15, 2022
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
Michael Turrin Maintained (BLND) at Buy with Decreased Target to $11 on, Mar 15th, 2022
Michael Turrin of Wells Fargo, Maintained "Blend Labs, Inc." (BLND) at Buy with Decreased Target from $15 to $11 on, Mar 15th, 2022.
Michael has made no other calls on BLND in the last 4 months.
There are 3 other peers that have a rating on BLND. Out of the 3 peers that are also analyzing BLND, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ryan Tomasello of "Keefe, Bruyette & Woods" Initiated at Hold and Held Target at $12 on, Monday, February 14th, 2022
These are the ratings of the 2 analyists that currently disagree with Michael
- Josh Beck of "Keybanc" Maintained at Buy with Decreased Target to $10 on, Tuesday, January 25th, 2022
- Arvind Ramnani of "Piper Sandler" Maintained at Buy with Decreased Target to $10 on, Thursday, January 13th, 2022
Contributing Sources